Sen. Bernie Sanders, I-Vt., is accusing Novo Nordisk, the maker of popular weight-loss drugs like Ozempic, of gouging prices for customers in the United States.
During a Tuesday appearance on MSNBC's "Ana Cabrera Reports," Sanders passionately pointed out the stark contrast in drug prices, stating that Novo Nordisk should not be charging people in the U.S. over $1,000 a month for the product while charging those who reside in places like Germany and Canada a fraction of the price.
"The American people, in my view, no matter what your political view may be, are sick and tired of being ripped off by drug companies and paying the highest prices in the world for prescription drugs, including Ozempic," Sanders told the media network.
Sanders also said Novo Nordisk must substantially lower the price they are charging Americans because of the large number of people dealing with diabetes and obesity who cannot afford the medicine.
Join the conversation as a VIP Member